American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Scinai Immunotherapeutics Ltd. (SCNI)

$0.23 -6.92% NASDAQ: SCNI · 15-min delayed

JERUSALEM,
Public · NASDAQ: SCNI
45 employees

Visit website Follow

$1.6MMarket cap

$1.3MRevenue · FY2025

-$8.3MNet income

45Employees

SCNINASDAQ

2015IPO

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: SCNI
Employees: 45
IPO date: May 12, 2015
Headquarters: JERUSALEM BIOPARK, 2ND FLOOR
JERUSALEM, 00000
Phone: 972-8-9302529
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: SCNI Nasdaq
SEC CIK: 1611747
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Embed this company’s badge

Show Scinai Immunotherapeutics Ltd.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/scinai-immunotherapeutics-ltd/"><img src="https://americancompanies.com/badge/scinai-immunotherapeutics-ltd.svg" alt="Scinai Immunotherapeutics Ltd. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow Scinai Immunotherapeutics Ltd. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $1.3M
Net income: -$8.3M
Total assets: $11.6M
Market cap: $1.6M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: SCNI

$0.23 -6.92%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.23 $2.52

52-week range

Market cap: $1.6M
Shares outstanding: 7.1M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 12, 2015

Scinai Immunotherapeutics Ltd. (SCNI) Stock Price

Reported a net loss of $8.3M in FY2025.
Trading 91% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Scinai Immunotherapeutics Ltd..

Write a review

Newsroom

News about Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe Benzinga · 2026-05-15 · positive Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price Benzinga · 2026-03-16 · negative Scinai Announces New Peer-Reviewed Publication Supporting PC111 as a Disease-Modifying Therapy for Pemphigus and SJS/TEN Benzinga · 2025-07-29 · positive Scinai Regains Full Compliance with Nasdaq Listing Requirements Benzinga · 2024-08-29 · positive Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance GlobeNewswire Inc. · 2023-11-03 Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update GlobeNewswire Inc. · 2023-10-31

News & sentiment via Polygon.io

FAQ

Scinai Immunotherapeutics Ltd.: frequently asked questions

Is Scinai Immunotherapeutics Ltd. an American company?

Scinai Immunotherapeutics Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Scinai Immunotherapeutics Ltd. publicly traded?

Yes — Scinai Immunotherapeutics Ltd. is a publicly traded company. Its stock trades under the ticker symbol SCNI on the NASDAQ.

What does Scinai Immunotherapeutics Ltd. do?

Scinai Immunotherapeutics Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore